Chaverra, M., George, L., Mergy, M., Waller, H., Kujawa, K., Murnion, C. Sharples, E., Thorne, J., Podgajny, N., Grindeland, A., Ueki, Y., Eiger, S., Cusick, C., Babcock, A., Carlson, G, Lefcort, F. (2017). The Familial Dysautonomia disease gene, ikbkal/Elp1, is required in the developing and adult central nervous system. Disease Models & Mechanisms, In Press

Bessen, R.A., Cameron J. Robinson C.J., Seelig, D.M., Watschke, C.P, Lowe, D., Shearin, H., Martinka S., Babcock, A.M. (2011). Transmission of chronic wasting disease identifies a prion strain causing cachexia and heart infection in hamsters PLoS One 6(12): e28026. doi:10.1371/journal.pone.0028026

journal of neuroscience research

Babcock, A.M., Standing, D., Bullshields, K., Spencer, K., Micevych, P.E., Poulsen, D.J. (2006). Over expression of hippocampal Calcium/calmodulin-dependent protein kinase II improves spatial memory. Journal of Neuroscience Research

pubmed

Babcock, A.M., Standing, D. Bullshields, K., Schwartz, E., C.M. Paden, Poulsen, D.J. (2005). In vivo inhibition of hippocampal Ca2+/calmodulin-dependent protein kinase II by RNA interference. Molecular Therapy. 11:899-905.

Babcock, A.M., Wright, J., Bjerkness, D., Hartman, H. & Tall Bear, N. (2002). Effects of prior apparatus experience and novelty of testing environment on locomotor activity following MK-801. Physiology and Behavior , 77:177-181.

Babcock A.M., Everingham, A., Paden, C.M. & Kimura, M. (2002). Baclofen is neuroprotective and prevents loss of calcium/calmodulin dependent protein kinase II immunoreactivity in the ischemic gerbil hippocampus. Journal of Neuroscience Research 67:804-811.

Babcock, A.M., Liu, H. Paden, C.M., Churn, S.B. & Pittman, A. (1999). In vivo glutamate neurotoxicity is associated with reductions in calcium/calmodulin-dependent protein kinase II immunoreactivity. Journal of Neuroscience Research 56:36-43.